[The prevention of anemia in premature infants: the role of recombinant human erythropoietin in a level III neonatology department].
Klosowski
S
S
Kongolo
G
G
Morisot
C
C
Thelliez
P
P
Djebara
A
A
Deroubaix
P
P
D000740:Anemia / Q000097:blood / Q000517:prevention & control* / Q000628:therapy; D001724:Birth Weight; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005865:Gestational Age; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D019102:Infant, Very Low Birth Weight; D011994:Recombinant Proteins; D012307:Risk Factors; D065227:Transfusion Reaction
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin
Prévention de l'anémie du prématuré: place de l'érythropoïétine humaine recombinante dans un service de néonatologie de niveau III.